References

1.. Duke-Elder S, Perkins ES: Diseases of the uveal tract.   In: Duke-Elder S, ed. System of Ophthalmology, vol. 9. St. Louis: Mosby; 1966.

2.. Albert DM, Diaz-Rohena R: A historical review of sympathetic ophthalmia and its epidemiology. Surv Ophthalmol  1989; 34:1-14.

3.. Zaharia MA, Lamarche J, Laurin M: Sympathetic uveitis 66 years after injury. Can J Ophthalmol  1984; 19:240-243.

5.. Liddy BSL, Stuart J: Sympathetic ophthalmia in Canada. Can J Ophthalmol  1972; 7:157-159.

7.. Gass JDM: Sympathetic ophthalmia following vitrectomy. Am J Ophthalmol  1982; 93:552-558.

8.. Chan CC, Roberge RG, Whitcup SM, et al: 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, MD, from 1982 to 1992. Arch Ophthalmol  1995; 113:597-600.

9.. Su DH, Chee SP: Sympathetic ophthalmia in Singapore: new trends in an old disease. Graefes Arch Clin Exp Ophthalmol  2006; 244:243-247.

11.. Sharp DC, Bell RA, Patterson E, et al: Sympathetic ophthalmia. Histopathologic and fluorescein angiographic correlation. Arch Ophthalmol  1984; 102:232-235.

12.. Bernasconi O, Auer C, Zografos L, et al: Indocyanine green angiographic findings in sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol  1998; 236:635-638.

14.. Shindo Y, Ohno S, Usui M, et al: Immunogenetic study of sympathetic ophthalmia. Tissue Antigens  1997; 49:111-115.

15.. Moorthy RS, Inomata H, Rao NA: Vogt–Koyanagi–Harada syndrome. Surv Ophthamol  1995; 39:265-292.

17.. Makley Jr TA, Azar A: Sympathetic ophthalmia. A long-term follow-up. Arch Ophthalmol  1978; 96:257-262.

18.. Reynard M, Riffenburg RS, Maes EF: Effects of corticosteroid treatment and enucleation on the visual prognosis of sympathetic ophthalmia. Am J Ophthalmol  1983; 96:290-294.

20.. Jakobiec FA, Marboe CC, Knowles DM, et al: Human sympathetic ophthalmia. An analysis of the inflammatory infiltrate by hybridoma-monoclonal antibodies, immunohistochemistry, and correlative electron microscopy. Ophthalmology  1983; 90:76-95.

21.. Chan CC, Benezra D, Rodrigues MM, et al: Immunohistochemistry and electron microscopy of choroidal infiltrates and Dalen–Fuchs nodules in sympathetic ophthalmia. Ophthalmology  1985; 92:580-590.

22.. Ishikawa T, Ikui H: The fine structure of the Dalen–Fuchs nodule in sympathetic ophthalmia. Report 1. Changes of the pigment epithelial cells within the Dalen–Fuchs nodules. Jpn J Ophthalmol  1972; 16:254-265.

23.. Front RL, Fine BS, Messmer E, et al: Light and electron microscopic study of Dalen–Fuchs nodules in sympathetic ophthalmia. Ophthalmology  1983; 90:66-75.

24.. Inomata H, Rao NA: Depigmented atrophic lesions in sunset glow fundi of Vogt–Koyanagi–Harada disease. Am J Ophthalmol  2001; 131:607-614.

26.. Marak Jr GE, Ikui H: Pigmentation associated histopathological variations in sympathetic ophthalmia. Br J Ophthalmol  1980; 64:220-222.

27.. Davis JL, Mittal KK, Freidlin V, et al: HLA associations and ancestry in Vogt–Koyanagi–Harada disease and sympathetic ophthalmia. Ophthalmology  1990; 97:1137-1142.

28.. Kilmartin DJ, Wilson D, Liversidge J, et al: Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol  2001; 85:281-286.

29.. Atan D, Turner SJ, Kilmartin DJ, et al: Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci  2005; 46:4245-4250.

31.. Ahmad N, Soong TK, Salvi S, et al: Sympathetic ophthalmia after ruthenium plaque brachytherapy. Br J Ophthalmol  2007; 91:399-401.

32.. Fries PD, Char DH, Crawford JB, et al: Sympathetic ophthalmia complicating helium ion irradiation of a choroidal melanoma. Arch Ophthalmol  1987; 105:1561-1564.

33.. Kilmartin DJ, Dick AD, Forrester JV: Sympathetic ophthalmia risk following vitrectomy: should we counsel patients?. Br J Ophthalmol  2000; 84:448-449.

34.. Green WR, Maumenee AE, Sanders TE, et al: Sympathetic ophthalmia following evisceration. Trans Am Acad Ophthalmol Otolaryngol  1972; 76:625-644.

35.. Ruedemann Jr AD: Sympathetic ophthalmia after evisceration. Am J Ophthalmol  1964; 57:770-790.

37.. Du Toit N, Motala MI, Richards J, et al: The risk of sympathetic ophthalmia following evisceration for penetrating eye injuries at Groote Schuur Hospital. Br J Ophthalmol  2008; 92:61-63.

38.. Rao NA, Wong VG: Aetiology of sympathetic ophthalmitis. Trans. Ophthalmol Soc UK  1981; 101:357-360.

39.. Wong VG, Anderson R, O’Brien PJ: Sympathetic ophthalmia and lymphocytic transformation. Am J Ophthalmol  1971; 72:960-966.

40.. Rao NA, Wacker WB, Marak Jr GE: Experimental allergic uveitis: clinicopathologic features associated with varying doses of S antigen. Arch Ophthalmol  1979; 97:1954-1958.

41.. Yamaki K, Gocho K, Hayakawa K, et al: Tyrosinase family proteins are antigens specific to Vogt–Koyanagi–Harada disease. J Immunol  2000; 165:7323-7329.

42.. Wu GS, Rao NA: A novel retinal pigment epithelial protein suppresses neutrophil superoxide generation I. Characterization of the suppressive factor. Exp Eye Res  1996; 63:713-725.

43.. Wu GS, Swiderek KM, Rao NA: A novel retinal pigment epithelial protein suppresses neutrophil superoxide generation II. Purification and microsequencing analysis. Exp Eye Res  1996; 63:727-737.